Recommended Protocol for Breast MRI Screening in High-Risk Patients
Annual breast MRI with IV contrast is recommended for high-risk women beginning as early as age 25, with annual mammography added at an appropriate age based on specific risk factors. 1
High-Risk Categories Requiring Breast MRI Screening
- Women with genetics-based increased risk (such as BRCA1/2 mutations) should undergo annual breast MRI starting at age 25-30, with annual mammography added at an appropriate age (typically between 25-40 depending on risk type) 1, 2
- Women with a calculated lifetime risk of 20% or more should receive annual breast MRI beginning at age 30, along with annual mammography 1
- Women with a history of chest or mantle radiation therapy at a young age should begin annual MRI at age 25 or 8 years after radiation therapy, whichever is later 1, 2
- Women with personal histories of breast cancer and dense breast tissue should undergo annual supplemental breast MRI 1, 2
- Women diagnosed with breast cancer before age 50 should receive annual MRI surveillance in addition to mammography 1, 2
Technical Protocol Specifications
- Full protocol breast MRI should be performed without and with IV contrast 1
- Abbreviated breast MRI protocols with IV contrast may be considered as an alternative, as studies show similar diagnostic accuracy to conventional full protocol MRI 1
- MRI without IV contrast is not supported by evidence for screening high-risk women 1
Performance Characteristics of Breast MRI in High-Risk Screening
- MRI combined with mammography yields 91-98% sensitivity for breast cancer detection in high-risk women 1
- The incremental cancer detection rate of MRI in high-risk women ranges from 8-29 per 1,000, with higher rates (26 per 1,000) in BRCA mutation carriers 1
- Breast MRI detects small, node-negative invasive cancers at earlier tumor stages compared to mammography 1
- Screening MRI reduces interval cancers in high-risk populations 1, 3
Important Considerations and Limitations
- Breast MRI has higher recall rates than mammography (15.1% versus 6.4%) 1
- Higher frequency of BI-RADS category 3 assessments with MRI compared to mammography (14.8% versus 11.8%) 1
- Greater frequency of image-guided biopsies with MRI than mammography (11.8 versus 2.4%) 1
- The very high negative predictive value of breast MRI (approaching 100%) makes it uniquely capable of ruling out cancer in appropriate circumstances 4
Alternative Screening Options
- For high-risk women who cannot undergo MRI, ultrasound should be considered as an alternative supplemental screening method 1
- Women should be counseled that ultrasound has inferior cancer detection rates compared to MRI 1, 5
- Contrast-enhanced mammography may be considered as an alternative to MRI in high-risk women 2, 5
- Adding ultrasound to the combination of mammography and MRI does not identify additional cancers and is therefore not routinely recommended 1, 6